Sponsored by

Genentech Biooncology

Please click on the above banner for more details

WEBSITECHANGES

You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.

Click HERE for details on RSS.

Displaying items 626 to 650 of about 5880

Previous 25

Website Changes

09/11/2021

The Importance of Shared Decision-Making for Patients with Glioblastoma

09/11/2021

A Month I Hope No Reader Must Face the Loss of A Child

09/07/2021

Lessons learned from contemporary glioblastoma randomized clinical trials through systematic review and network meta-analysis: part 2 newly diagnosed disease

09/05/2021

Does proton therapy have a role in the treatment of brain tumors?

08/28/2021

#CancelChildhoodCancer citizen petition campaign.

08/26/2021

Researchers Discover Treatment That May Be Viable For Human Brain Cancer

08/25/2021

A phase Ib/IIa trial of 9 repurposed drugs combined with temozolomide for the treatment of recurrent glioblastoma: CUSP9v3

08/25/2021

Help Us Better Understand Glioblastoma Multiforme

08/25/2021

Musella Foundation Copay Program now closed to new and renewal patients

08/12/2021

A phase Ib/IIa trial of 9 repurposed drugs combined with temozolomide for the treatment of recurrent glioblastoma: CUSP9v3

08/12/2021

Hackensack Meridian Children’s Health Children’s Cancer Institute Now a Member of the Pacific Pediatric Neuro-Oncology Consortium (PNOC)

08/11/2021

Musella Foundation Copay Assistance program is running low on funding

08/02/2021

Amazon Smile Fundraiser! Action Required!

07/30/2021

Help support the Promising Pathway Act

07/29/2021

Radiation therapy combined with intracerebral convection-enhanced delivery of cisplatin or carboplatin for treatment of the F98 rat glioma

07/29/2021

Phase I trial of intracerebral convection-enhanced delivery of carboplatin for treatment of recurrent high-grade gliomas

07/27/2021

Brain tumour patients and COVID-19 vaccines: IBTA international survey

07/26/2021

Tumor-Treating Fields for the treatment of glioblastoma: a systematic review and meta-analysis

07/26/2021

Case Report: End-Stage Recurrent Glioblastoma Treated With a New Noninvasive Non-Contact Oncomagnetic Device

07/26/2021

COMBINATION OF TUMOR TREATING FIELDS (TTFIELDS) WITH LOMUSTINE (CCNU) AND TEMOZOLOMIDE (TMZ) IN NEWLY DIAGNOSED GLIOBLASTOMA (GBM) PATIENTS - A BI-CENTRIC ANALYSIS

07/24/2021

A genetic mutation causing DMG and a potential drug to treat it

07/21/2021

KIYATEC Marks Glioblastoma Awareness Day by Initiating Use of 3D Predict™ Glioma Test Outside of Clinical Study

07/17/2021

The 2021 WHO Classification of Tumors of the Central Nervous System: a summary

07/10/2021

Nivolumab Plus Standard- or Reduced-Dosed Bevacizumab for Recurrent Glioblastoma

07/09/2021

Musella Foundation awards two brain tumor research grants!

Our privacy / cookie policy has changed.
Click HERE to read it!